Tumor Ablation Market Size, Share & Trends by Technology (Radiofrequency, Microwave, Laser, IRE, HIFU, Cryoablation), Product (Generators, Probes), Mode (Surgical, Laparoscopic, Percutaneous), Cancer (Liver, Lung, Bone), End User (Hospitals, Clinic) & Reg

Tumor Ablation Market Size, Share & Trends by Technology (Radiofrequency, Microwave, Laser, IRE, HIFU, Cryoablation), Product (Generators, Probes), Mode (Surgical, Laparoscopic, Percutaneous), Cancer (Liver, Lung, Bone), End User (Hospitals, Clinic) & Region - Global Forecast to 2029



The global tumor ablation market is projected to reach USD 1.4 billion by 2029 from USD 0.8 billion in 2024, at a CAGR of 10.0% from 2024 to 2029. Aging population, coupled with a rise in tumor cases such as osteoid osteoma, has increased the demand for these products. Moreover, increased awareness of ablation procedures over conventional procedures has driven demand for tumor ablation systems.

“The radiofrequency ablation segment of technology segment held the largest share of the market in 2023”

The tumor ablation market is segmented based on technology into radiofrequency ablation, microwave ablation, laser ablation, high-intensity focused ultrasound (HIFU), cryoablation, and irreversible electroporation (IRE). As the global population ages, conditions affecting the major organs are more prevalent, contributing to the demand for supportive and rehabilitative solutions. Additionally, advancements in technology have led to the development and incorporation of ablation systems, expanding the market further.

“The generators segment is projected to register the highest CAGR during the forecast period.”

Based on product type, the tumor ablation market is segmented into generators and probes/electrodes. The generators segment accounted for the largest market share in 2023. The probes/electrodes market is witnessing growth due to recent regulatory approvals of ablation systems and favourable reimbursement policies. The probes/electrodes have undergone certain technological advancements supporting the precise ablation procedure. The growing awareness of the importance of early detection and the shift towards value-based healthcare has also contributed to the increasing demand for soft and elastic braces and its growing market.

“The laparoscopic ablation segment for mode of treatment segment is projected to register a significant CAGR during the forecast period.”

Based on mode of treatment, the tumor ablation market is segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation . The surgical ablation segment accounted for the largest market share in 2023. Growing investments in R&D and rising demand for less invasive alternative is driving the growth of this segment.

“The liver cancer segment for application segment held held the largest share of the market in 2022”.

Based on application, the tumor ablation market is segmented into liver cancer, lung cancer, bone cancer, kidney cancer, and other applications. The liver cancer was the major segment, accounted for the largest share of the tumor ablation market in 2023. Rising cancer incidence is supported by the increasing aging population. This ultimately drives the adoption of tumor ablation systems. A rising number of campaigns for the early detection of symptoms is also contributing to the increasing utilization of ablation treatment in end-user facilities.

“The cancer care center segment for the end user segment is projected to register a significant CAGR during the forecast period.”

The tumor ablation market is segmented by end user into hospitals and clinics, cancer care centers, and ambulatory surgery centers. The hospitals and clinics segment accounted for a significant market share in 2023. The emphasis on non- and minimally invasive treatment among the geriatric population helps the growing preference for ablation treatment solutions, driving the integration of tumor ablation systems into hospital settings.

“The market in the North America region is expected to witness the highest growth during the forecast period.”

The North America tumor ablation market is expected to hold a major share during the forecast period. The US market holds a dominating position in the North American market, primarily due to the region's high healthcare spending, rising prevalence of target diseases, a growing number of non-invasive treatments, and technological advancements in ablation systems.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%

By Designation: Director-level–10%, C-level–14%, and Others–76%

By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%

The prominent players in the tumor ablation market are Medtronic Plc (Ireland), Johnson & Johnson MedTech (US), Stryker Corporation (US), Varian Medical Systems, Inc. (US), AngioDynamics, Inc. (US), Boston Scientific Corporation (US) among others.

Research Coverage

This report studies the tumor ablation market based on technology, product type, mode of treatment, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall tumor ablation market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

Analysis of key drivers (increasing cancer incidence and rising geriatric population, rising focus on minimally invasive procedures, technological advancements in the field of tumor ablation, rising number of awareness campaigns and early detection), restraints (high cost of tumor ablation systems, unfavorable reimbursement scenario), opportunities (rising healthcare expenditure across emerging countries, increasing number of hospitals), and challenges (rising adoption of refurbished tumor ablation systems, hospital budget cuts) influencing the growth of the tumor ablation market

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the tumor ablation market

Market Development: Comprehensive information about lucrative markets–the report analyses the tumor ablation market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the tumor ablation market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players – such as Johnson & Johnson (US), Medtronic Plc (Ireland), Stryker Corporation (US), Varian Medical Systems, Inc. (US), Olympus (Japan), AngioDynamics, Inc. (US), Boston Scientific Corporation (US) among others.


  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
      • INCLUSIONS & EXCLUSIONS
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED
      • CURRENCY CONSIDERED
    • RESEARCH LIMITATIONS
    • KEY STAKEHOLDERS
    • SUMMARY OF CHANGES
    • RECESSION IMPACT
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
    • DATA VALIDATION APPROACH
    • MARKET SHARE ASSESSMENT
    • STUDY ASSUMPTIONS
    • GROWTH RATE ASSUMPTIONS
    • RISK ASSESSMENT
    • RECESSION IMPACT ANALYSIS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • TUMOR ABLATION MARKET OVERVIEW
    • NORTH AMERICA: TUMOR ABLATION MARKET, BY TECHNOLOGY
    • EUROPE: TUMOR ABLATION MARKET, BY APPLICATION
    • ASIA PACIFIC: TUMOR ABLATION MARKET, BY END USER
    • GEOGRAPHIC SNAPSHOT OF TUMOR ABLATION MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
    • REGULATORY ANALYSIS
      • KEY REGULATORY BODIES AND GOVERNMENT AGENCIES
        • Table NORTH AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
        • Table EUROPE: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
        • Table ASIA PACIFIC: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
        • Table LATIN AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
        • Table MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
      • KEY REGULATORY GUIDELINES
        • Table US FDA: MEDICAL DEVICE CLASSIFICATION
        • Table US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
        • Table CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
        • Table JAPAN: PMDA CLASSIFICATION OF ABLATION DEVICES
        • Table JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
        • Table CHINA: CLASSIFICATION OF MEDICAL DEVICES
        • Table INDIA: CDSCO CLASSIFICATION OF ABLATION DEVICES
    • REIMBURSEMENT SCENARIO
      • Table MEDICAL REIMBURSEMENT CPT CODES FOR MICROWAVE AND RADIOFREQUENCY ABLATION PROCEDURES IN US (EFFECTIVE JANUARY 1, 2022)
    • VALUE CHAIN ANALYSIS
      • RESEARCH & DEVELOPMENT
      • MANUFACTURING & ASSEMBLY
      • DISTRIBUTION, MARKETING & SALES, AND POST -SALES SERVICES
    • SUPPLY CHAIN ANALYSIS
      • PROMINENT COMPANIES
      • SMALL AND MEDIUM-SIZED ENTERPRISES
      • END USERS
    • ECOSYSTEM ANALYSIS
      • Table TUMOR ABLATION MARKET: ROLE IN ECOSYSTEM
    • INVESTMENT & FUNDING SCENARIO
    • PRICING ANALYSIS
      • Table AVERAGE SELLING PRICE OF TUMOR ABLATION SYSTEMS, BY REGION, 2021–2023
    • TRADE ANALYSIS
      • Table IMPORT DATA FOR TUMOR ABLATION SYSTEMS (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
      • Table EXPORT DATA FOR TUMOR ABLATION SYSTEMS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND)
    • PATENT ANALYSIS
    • PORTER’S FIVE FORCE ANALYSIS
      • Table PORTER’S FIVE FORCES ANALYSIS: TUMOR ABLATION MARKET
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • KEY CONFERENCES & EVENTS IN 2024–2025
      • Table LIST OF MAJOR CONFERENCES & EVENTS IN TUMOR ABLATION MARKET, 2024–2025
    • CASE STUDY ANALYSIS
      • Table CASE STUDY 1: RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY
      • Table CASE STUDY 2: ABLATION OF LOCALIZED RENAL TUMOR
    • TECHNOLOGY ANALYSIS
      • KEY TECHNOLOGIES
      • COMPLEMENTARY TECHNOLOGIES
      • ADJACENT TECHNOLOGIES
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    • KEY STAKEHOLDERS & BUYING CRITERIA
      • KEY STAKEHOLDERS IN BUYING PROCESS
        • Table INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
      • BUYING CRITERIA
        • Table KEY BUYING CRITERIA FOR TUMOR ABLATION SYSTEMS
    • UNMET NEEDS & KEY PAIN POINTS
      • Table TUMOR ABLATION MARKET: CURRENT UNMET NEEDS
  • TUMOR ABLATION MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
    • RADIOFREQUENCY ABLATION
      • LOW COST OF RADIOFREQUENCY ABLATION TO CONTRIBUTE TO MARKET GROWTH
        • Table RADIOFREQUENCY ABLATION MARKET, BY REGION, 2022–2029 (USD MILLION)
    • MICROWAVE ABLATION
      • ADVANTAGES OF MICROWAVE ABLATION TO BOOST MARKET GROWTH
        • Table MICROWAVE ABLATION MARKET, BY REGION, 2022–2029 (USD MILLION)
    • CRYOABLATION
      • HIGH SAFETY AND EFFICACY OF CRYOABLATION TO BOOST MARKET
        • Table CRYOABLATION MARKET, BY REGION, 2022–2029 (USD MILLION)
    • HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU)
      • TECHNOLOGICAL ADVANCEMENTS IN ULTRASOUND ABLATION TO FAVOR MARKET GROWTH
        • Table HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET, BY REGION, 2022–2029 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table OTHER TUMOR ABLATION TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TUMOR ABLATION MARKET, BY PRODUCT TYPE
    • INTRODUCTION
      • Table TUMOR ABLATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
      • Table TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (UNITS)
    • GENERATORS
      • RISING ADOPTION OF TUMOR ABLATION SYSTEMS TO PROPEL MARKET GROWTH
        • Table TUMOR ABLATION GENERATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
    • PROBES/ELECTRODES
      • RADIOFREQUENCY ABLATION PROBES
        • Table RADIOFREQUENCY ABLATION PROBES MARKET, BY REGION, 2022–2029 (USD MILLION)
      • MICROWAVE ABLATION PROBES
        • Table MICROWAVE ABLATION PROBES MARKET, BY REGION, 2022–2029 (USD MILLION)
      • OTHER PROBES/ELECTRODES
        • Table OTHER TUMOR ABLATION PROBES/ELECTRODES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TUMOR ABLATION MARKET, BY MODE OF TREATMENT
    • INTRODUCTION
      • Table TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2022–2029 (USD MILLION)
    • SURGICAL ABLATION
      • RISING UTILIZATION OF SURGICAL ABLATION IN END-USER FACILITIES TO PROPEL MARKET
        • Table TUMOR ABLATION MARKET FOR SURGICAL ABLATION, BY REGION, 2022–2029 (USD MILLION)
    • LAPAROSCOPIC ABLATION
      • IMPROVED SUCCESS RATE AND REAL-TIME VISUALIZATION TO BOOST DEMAND
        • Table TUMOR ABLATION MARKET FOR LAPAROSCOPIC ABLATION, BY REGION, 2022–2029 (USD MILLION)
    • PERCUTANEOUS ABLATION
      • SHORTER RECOVERY TIME AND COST -EFFECTIVENESS OF PROCEDURE TO DRIVE SEGMENT
        • Table TUMOR ABLATION MARKET FOR PERCUTANEOUS ABLATION, BY REGION, 2022–2029 (USD MILLION)
  • TUMOR ABLATION MARKET, BY APPLICATION
    • INTRODUCTION
      • Table TUMOR ABLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
    • LIVER CANCER
      • PROMISING OUTCOMES OF ABLATION IN TREATING HCC TO DRIVE MARKET
        • Table TUMOR ABLATION MARKET FOR LIVER CANCER, BY REGION, 2022–2029 (USD MILLION)
    • LUNG CANCER
      • RISING INCIDENCE OF LUNG CANCER TO FUEL MARKET
        • Table TUMOR ABLATION MARKET FOR LUNG CANCER, BY REGION, 2022–2029 (USD MILLION)
    • KIDNEY CANCER
      • RISING PREVALENCE OF KIDNEY CANCER AND MINIMAL DAMAGE OF HEALTHY TISSUE TO DRIVE ADOPTION
        • Table TUMOR ABLATION MARKET FOR KIDNEY CANCER, BY REGION, 2022–2029 (USD MILLION)
    • BONE CANCER
      • RISING USE OF ABLATION TECHNIQUES TO TREAT OSTEOID OSTEOMA TO BOOST GROWTH
        • Table TUMOR ABLATION MARKET FOR BONE CANCER, BY REGION, 2022–2029 (USD MILLION)
    • OTHER APPLICATIONS
      • Table TUMOR ABLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TUMOR ABLATION MARKET, BY END USER
    • INTRODUCTION
      • Table TUMOR ABLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
    • HOSPITALS & CLINICS
      • INCREASING ADOPTION OF ADVANCED TUMOR ABLATION SYSTEMS TO PROPEL MARKET
        • Table TUMOR ABLATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION)
    • CANCER CARE CENTERS
      • GROWING ESTABLISHMENT OF CANCER CARE CENTERS TO FUEL MARKET
        • Table TUMOR ABLATION MARKET FOR CANCER CARE CENTERS, BY REGION, 2022–2029 (USD MILLION)
    • OTHER END USERS
      • Table TUMOR ABLATION MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TUMOR ABLATION MARKET, BY REGION
    • INTRODUCTION
      • Table TUMOR ABLATION MARKET, BY REGION, 2022–2029 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: TUMOR ABLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
      • Table NORTH AMERICA: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • Table NORTH AMERICA: TUMOR ABLATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
      • Table NORTH AMERICA: TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2022–2029 (USD MILLION)
      • Table NORTH AMERICA: TUMOR ABLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
      • Table NORTH AMERICA: TUMOR ABLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
      • NORTH AMERICA: RECESSION IMPACT
      • US
        • Table US: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • CANADA
        • Table CANADA: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
    • EUROPE
      • Table EUROPE: TUMOR ABLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
      • Table EUROPE: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • Table EUROPE: TUMOR ABLATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
      • Table EUROPE: TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2022–2029 (USD MILLION)
      • Table EUROPE: TUMOR ABLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
      • Table EUROPE: TUMOR ABLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
      • EUROPE: RECESSION IMPACT
      • GERMANY
        • Table GERMANY: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • FRANCE
        • Table FRANCE: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • UK
        • Table UK: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • ITALY
        • Table ITALY: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • SPAIN
        • Table SPAIN: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: TUMOR ABLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
      • Table ASIA PACIFIC: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • Table ASIA PACIFIC: TUMOR ABLATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
      • Table ASIA PACIFIC: TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2022–2029 (USD MILLION)
      • Table ASIA PACIFIC: TUMOR ABLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
      • Table ASIA PACIFIC: TUMOR ABLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
      • ASIA PACIFIC: RECESSION IMPACT
      • JAPAN
        • Table JAPAN: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • CHINA
        • Table CHINA: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • INDIA
        • Table INDIA: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • AUSTRALIA
        • Table AUSTRALIA: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • SOUTH KOREA
        • Table SOUTH KOREA: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
    • LATIN AMERICA
      • LATIN AMERICA: RECESSION IMPACT
        • Table LATIN AMERICA: TUMOR ABLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
        • Table LATIN AMERICA: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
        • Table LATIN AMERICA: TUMOR ABLATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
        • Table LATIN AMERICA: TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2022–2029 (USD MILLION)
        • Table LATIN AMERICA: TUMOR ABLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
        • Table LATIN AMERICA: TUMOR ABLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • MEXICO
        • Table MEXICO: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
      • REST OF LATIN AMERICA
        • Table REST OF LATIN AMERICA: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH
        • Table MIDDLE EAST & AFRICA: TUMOR ABLATION MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: TUMOR ABLATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2022–2029 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: TUMOR ABLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: TUMOR ABLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
      • MIDDLE EAST & AFRICA: RECESSION IMPACT
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • KEY PLAYER STRATEGIES/RIGHT TO WIN
      • OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN TUMOR ABLATION MARKET
        • Table OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
    • REVENUE ANALYSIS
    • MARKET SHARE ANALYSIS
      • Table TUMOR ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION
    • COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
      • COMPANY FOOTPRINT: KEY PLAYERS, 2023
        • Table TUMOR ABLATION MARKET: TECHNOLOGY FOOTPRINT
        • Table TUMOR ABLATION MARKET: REGION FOOTPRINT
    • COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
      • PROGRESSIVE COMPANIES
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
      • STARTING BLOCKS
      • COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
        • Table TUMOR ABLATION MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
        • Table TUMOR ABLATION MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
    • COMPANY VALUATION & FINANCIAL METRICS
      • FINANCIAL METRICS
      • COMPANY VALUATION
    • BRAND/PRODUCT COMPARISON
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES/APPROVALS
        • Table TUMOR ABLATION MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
      • DEALS
        • Table TUMOR ABLATION MARKET: DEALS, JANUARY 2021–MARCH 2024
      • EXPANSIONS
        • Table TUMOR ABLATION MARKET: EXPANSIONS, JANUARY 2021–MARCH 2024
  • COMPANY PROFILES
    • KEY PLAYERS
      • MEDTRONIC PLC
        • Table MEDTRONIC PLC: COMPANY OVERVIEW
        • Table MEDTRONIC PLC: PRODUCTS OFFERED
        • Table MEDTRONIC PLC: PRODUCT APPROVALS
      • JOHNSON & JOHNSON MEDTECH (ETHICON)
        • Table JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
        • Table JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
      • STRYKER CORPORATION
        • Table STRYKER CORPORATION: COMPANY OVERVIEW
        • Table STRYKER CORPORATION: PRODUCTS OFFERED
        • Table STRYKER CORPORATION: PRODUCT APPROVALS
        • Table STRYKER CORPORATION: EXPANSIONS
      • VARIAN MEDICAL SYSTEMS, INC.
        • Table VARIAN MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
        • Table VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
        • Table VARIAN MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES
        • Table VARIAN MEDICAL SYSTEMS, INC.: DEALS
      • ANGIODYNAMICS, INC.
        • Table ANGIODYNAMICS, INC.: COMPANY OVERVIEW
        • Table ANGIODYNAMICS, INC.: PRODUCTS OFFERED
        • Table ANGIODYNAMICS, INC.: DEALS
      • BOSTON SCIENTIFIC CORPORATION
        • Table BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
        • Table BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
      • EDAP TMS S.A.
        • Table EDAP TMS S.A.: COMPANY OVERVIEW
        • Table EDAP TMS S.A.: PRODUCTS OFFERED
      • MERMAID MEDICAL
        • Table MERMAID MEDICAL: COMPANY OVERVIEW
        • Table MERMAID MEDICAL: PRODUCTS OFFERED
      • CANYON MEDICAL INC.
        • Table CANYON MEDICAL INC.: COMPANY OVERVIEW
        • Table CANYON MEDICAL INC.: PRODUCTS OFFERED
      • OLYMPUS CORPORATION
        • Table OLYMPUS CORPORATION: COMPANY OVERVIEW
        • Table OLYMPUS CORPORATION: PRODUCTS OFFERED
        • Table OLYMPUS CORPORATION: PRODUCT LAUNCHES
      • CHONGQING HAIFU MEDICAL TECHNOLOGY CO., LTD.
        • Table CHONGQING HAIFU MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
        • Table CHONGQING HAIFU MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
      • MERIT MEDICAL SYSTEMS, INC.
        • Table MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
        • Table MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
      • BIOVENTUS INC.
        • Table BIOVENTUS INC.: COMPANY OVERVIEW
        • Table BIOVENTUS INC.: PRODUCTS OFFERED
        • Table BIOVENTUS INC.: DEALS
      • ICECURE MEDICAL LTD.
        • Table ICECURE MEDICAL LTD.: COMPANY OVERVIEW
        • Table ICECURE MEDICAL LTD.: PRODUCTS OFFERED
        • Table ICECURE MEDICAL LTD.: PRODUCT APPROVALS
        • Table ICECURE MEDICAL LTD.: DEALS
      • CONMED CORPORATION
        • Table CONMED CORPORATION: COMPANY OVERVIEW
        • Table CONMED CORPORATION: PRODUCTS OFFERED
    • OTHER PLAYERS
      • MONTERIS MEDICAL
      • MIANYANG SONIC ELECTRONIC
      • RF MEDICAL
      • MINIMAX MEDICAL HOLDING GROUP
      • SONABLATE
      • ECO MEDICAL TECHNOLOGY (NANJING) CO., LTD.
      • STARMED CO., LTD.
      • SURGNOVA
      • CREO MEDICAL
      • MEDSPHERE SHANGHAI
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings